Acorda Therapeutics, Inc.
USD0.66
-0.21 (-24.02%)
CEO
Ron Cohen
IPO Date
2006-02-10
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.78
Prev. Close
$0.87
Day Low
$0.61
Day High
$0.85
52W Low
$0.61
52W High
$24.20
Market Cap
$0.00B
Volume
0.32M
| -0.0 |
| 31 Dec 2021 | FY | 68.4% | -80.5% | -68.8% | -22.8% | 1.26 | 1.89 | -0.0 |
| 31 Dec 2020 | FY | 78.1% | -65.1% | -41.9% | -15.7% | 1.09 | 1.61 | -0.1 |
| 31 Dec 2019 | FY | 81.9% | -141.9% | -87.8% | -34.1% | 0.80 | 2.33 | -0.1 |
| 31 Dec 2018 | FY | 78.9% | 7.1% | 5.5% | 2.6% | 0.56 | 3.77 | 3.6 |
| 31 Dec 2017 | FY | 76.9% | -38.0% | -43.0% | -18.6% | 0.64 | 3.07 | -0.7 |
| 31 Dec 2016 | FY | 79.2% | -6.7% | -5.3% | -2.6% | 0.51 | 1.87 | -4.1 |
| 31 Dec 2015 | FY | 81.1% | 2.2% | 1.8% | 1.0% | 0.49 | 5.01 | 28.1 |
| 31 Dec 2014 | FY | 79.9% | 4.4% | 3.3% | 1.6% | 0.53 | 3.58 | 16.2 |
| -0.0 |
| 30 Sept 2023 | Q3 | 87.8% | -32.1% | -15.1% | -2.4% | 3.16 | 1.59 | -0.1 |
| 30 Jun 2023 | Q2 | 89.7% | -31.6% | -13.8% | -2.6% | 2.67 | 2.14 | -0.1 |
| 31 Mar 2023 | Q1 | 85.5% | -75.6% | -21.9% | -4.5% | 2.30 | 1.96 | -0.0 |
| 31 Dec 2022 | Q4 | 85.5% | 60.8% | 20.4% | 4.8% | 1.85 | 2.16 | 0.0 |
| 30 Sept 2022 | Q3 | 67.2% | -41.3% | -18.3% | -3.5% | 2.56 | 1.71 | -0.0 |
| 30 Jun 2022 | Q2 | 71.7% | -150.3% | -53.1% | -11.5% | 2.18 | 1.86 | -0.0 |
| 31 Mar 2022 | Q1 | 73.5% | -108.8% | -19.2% | -5.8% | 1.52 | 1.75 | -0.0 |
| 31 Dec 2021 | Q4 | 88.6% | -55.6% | -13.6% | -4.5% | 1.26 | 1.89 | -0.1 |